<DOC>
	<DOCNO>NCT00099216</DOCNO>
	<brief_summary>The goal research study evaluate effectiveness , tolerability safety rivastigmine capsule male female age 50 85 year old probable vascular dementia .</brief_summary>
	<brief_title>Efficacy Safety Rivastigmine Capsules Patients With Probable Vascular Dementia</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Between age 50 85 year old Have contact responsible caregiver 3 day per week Be male female surgically sterilize one year post menopausal Current diagnosis severe unstable cardiovascular disease Current diagnosis active , uncontrolled seizure disorder , Parkinson 's disease Alzheimer 's disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Dementia , vascular , rivastigmine , stroke , memory loss</keyword>
</DOC>